G1 cell-cycle control and cancer - PubMed (original) (raw)

Review

. 2004 Nov 18;432(7015):298-306.

doi: 10.1038/nature03094.

Affiliations

• PMID: 15549091
• DOI: 10.1038/nature03094

Review

G1 cell-cycle control and cancer

Joan Massagué. Nature. 2004.

Abstract

Before replicating DNA during their reproductive cycle, our cells enter a phase called G1 during which they interpret a flood of signals that influence cell division and cell fate. Mistakes in this process lead to cancer. An increasingly complex and coherent view of G1 signalling networks, which coordinate cell growth, proliferation, stress management and survival, is helping to define the roots of malignancies and shows promise for the development of better cancer therapies.

PubMed Disclaimer

Similar articles

• G1 and S-phase checkpoints, chromosome instability, and cancer.
  Nojima H. Nojima H. Methods Mol Biol. 2004;280:3-49. doi: 10.1385/1-59259-788-2:003. Methods Mol Biol. 2004. PMID: 15187248 Review.
• The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.
  Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. Mishra L, et al. Oncogene. 2005 Aug 29;24(37):5775-89. doi: 10.1038/sj.onc.1208924. Oncogene. 2005. PMID: 16123810 Review.
• Pathways governing G1/S transition and their response to DNA damage.
  Bartek J, Lukas J. Bartek J, et al. FEBS Lett. 2001 Feb 16;490(3):117-22. doi: 10.1016/s0014-5793(01)02114-7. FEBS Lett. 2001. PMID: 11223026 Review.
• DNA damage checkpoints: implications for cancer therapy.
  O'Connor PM, Fan S. O'Connor PM, et al. Prog Cell Cycle Res. 1996;2:165-73. doi: 10.1007/978-1-4615-5873-6_16. Prog Cell Cycle Res. 1996. PMID: 9552393 Review.
• Cancer cell cycles.
  Sherr CJ. Sherr CJ. Science. 1996 Dec 6;274(5293):1672-7. doi: 10.1126/science.274.5293.1672. Science. 1996. PMID: 8939849 Review.

Cited by

• Alternative splicing is coupled to gene expression in a subset of variably expressed genes.
  Karlebach G, Steinhaus R, Danis D, Devoucoux M, Anczuków O, Sheynkman G, Seelow D, Robinson PN. Karlebach G, et al. NPJ Genom Med. 2024 Nov 4;9(1):54. doi: 10.1038/s41525-024-00432-w. NPJ Genom Med. 2024. PMID: 39496626 Free PMC article.
• Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors.
  Wang J, Fang S, Jiang Y, Hua Q. Wang J, et al. Clin Med Insights Oncol. 2024 Oct 9;18:11795549241281932. doi: 10.1177/11795549241281932. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 39391229 Free PMC article. Review.
• Lineage-specific CDK activity dynamics characterize early mammalian development.
  Saykali B, Tran AD, Cornwell JA, Caldwell MA, Sangsari PR, Morgan NY, Kruhlak MJ, Cappell SD, Ruiz S. Saykali B, et al. bioRxiv [Preprint]. 2024 Jun 14:2024.06.14.599098. doi: 10.1101/2024.06.14.599098. bioRxiv. 2024. PMID: 39372752 Free PMC article. Preprint.
• TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma.
  Li J, Chen M, Tong M, Cao Q. Li J, et al. Front Immunol. 2024 Sep 5;15:1457691. doi: 10.3389/fimmu.2024.1457691. eCollection 2024. Front Immunol. 2024. PMID: 39301023 Free PMC article.
• The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer.
  Kamal A, Boerner J, Assad H, Chen W, Simon MS. Kamal A, et al. Int J Mol Sci. 2024 Sep 4;25(17):9587. doi: 10.3390/ijms25179587. Int J Mol Sci. 2024. PMID: 39273534 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database